DRKS00026150

Prospective, monocentric observational study on the clinical use and patient satisfaction of pfmmedical implantable vascular access ports

Organizational Data

DRKS-ID:
DRKS00026150
Recruitment Status:
Recruiting complete, study continuing
Date of registration in DRKS:
2022-06-22
Last update in DRKS:
2023-01-09
Registration type:
Retrospective

Acronym/abbreviation of the study

PMCF study pfmmedical Ports

URL of the study

No Entry

Brief summary in lay language

The aim of this observational study is to collect follow-up data on implantable ports in the course of post market surveillance for a period of up to six months. The focus is on patient satisfaction and the safety of the implantable ports during and after implantation.

Brief summary in scientific language

Prospective, monocentric, non-randomised, observational post-market clinical follow-up study in Germany to obtain post-market information on the pfmmedical ports with a follow-up (FU) of six months. The focus is on patient reported satisfaction, clinical application, and complication rates.

Health condition or problem studied

ICD-10-GM (translation):
Z95.81
Healthy volunteers:
No Entry

Interventions, Observational Groups

Arm 1:
Patients with a medical indication for port implantation

Endpoints

Primary outcome:
The study hypothesis is that the patients’ satisfaction after the study intervention is not worse than the satisfaction identified in the current literature. Satisfaction is determined using the patient questionnaire (six months after implantation).
Secondary outcome:
none

Study Design

Purpose:
Treatment
Retrospective/prospective:
No Entry
Study type:
Non-interventional
Longitudinal/cross-sectional:
No Entry
Study type non-interventional:
No Entry

Recruitment

Recruitment Status:
Recruiting complete, study continuing
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Monocenter study
Recruitment location(s):
  • University medical center Universitätsklinikum Heidelberg Portzentrum Heidelberg

Recruitment period and number of participants

Planned study start date:
No Entry
Actual study start date:
2022-04-13
Planned study completion date:
No Entry
Actual Study Completion Date:
No Entry
Target Sample Size:
150
Final Sample Size:
150

Inclusion Criteria

Sex:
All
Minimum Age:
18 Years
Maximum Age:
no maximum age
Additional Inclusion Criteria:
• Age: ≥ 18 years • Medical indication for port catheter implantation. • The patient is mentally able to understand the nature, aims and possible consequences of the PMCF study. • Patient information has been provided and written consent exists.

Exclusion Criteria

• Contraindications according to the manufacturer´s instructions for use (IFU). • The patient is institutionalised by court or official order (MPDG §27). • Patient participates in another operative clinical investigation if it relates to the area of port devices and/or influences the primary endpoint of the PMCF study. • Patients who currently already have a port implanted.

Addresses

Primary Sponsor

Address:
pfm medical ag
Wankelstr. 60
50996 Köln
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.pfmmedical.com
Investigator Sponsored/Initiated Trial (IST/IIT):
No

Contact for Scientific Queries

Address:
pfm medical ag
Kai Braunsteffer
Wankelstraße 60
50996 Köln
Germany
Telephone:
+49 (2236) 9641 226
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.pfmmedical.com

Contact for Public Queries

Address:
pfm medical ag
Kai Braunsteffer
Wankelstraße 60
50996 Köln
Germany
Telephone:
+49 (2236) 9641 226
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.pfmmedical.com

Principal Investigator

Address:
pfm medical ag
Kai Braunsteffer
Wankelstraße 60
50996 Köln
Germany
Telephone:
+49 (2236) 9641 226
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.pfmmedical.com

Sources of Monetary or Material Support

Commercial (pharmaceutical industry, medical engineering industry, etc.)

Address:
pfm medical ag
Wankelstr. 60
50996 Köln
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.pfmmedical.com

Ethics Committee

Address Ethics Committee

Address:
Ethikkommission der Medizinischen Fakultät Heidelberg
Alte Glockengießerei 11/1
69115 Heidelberg
Germany
Telephone:
+49-6221-338220
Fax:
+49-6221-3382222
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2022-02-03
Ethics committee number:
S-080/2022
Vote of the Ethics Committee:
Approved
Date of the vote:
2022-03-02

Further identification numbers

Other WHO Primary Registry or Data Provider ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
No
IPD Sharing Plan:
No Entry

Study protocol and other study documents

Study protocols:
No Entry
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publications/study results:
No Entry
Date of the first journal publication of results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry